BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28669750)

  • 1. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET.
    Goossens S; Vandamme N; Van Vlierberghe P; Berx G
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):584-591. PubMed ID: 28669750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Post-Translational Regulation of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis.
    Kang E; Seo J; Yoon H; Cho S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check.
    Díaz VM; de Herreros AG
    Semin Cancer Biol; 2016 Feb; 36():71-9. PubMed ID: 26506454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.
    Tania M; Khan MA; Fu J
    Tumour Biol; 2014 Aug; 35(8):7335-42. PubMed ID: 24880591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts.
    Baulida J
    Mol Oncol; 2017 Jul; 11(7):847-859. PubMed ID: 28544627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT-ions with a TWIST between EMT and MET.
    Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
    Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of selected epithelial-mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers.
    Sadlecki P; Jóźwicki J; Antosik P; Grabiec M
    Tumour Biol; 2018 Jun; 40(6):1010428318784807. PubMed ID: 29952249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
    Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
    Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilayer control of the EMT master regulators.
    Zheng H; Kang Y
    Oncogene; 2014 Apr; 33(14):1755-63. PubMed ID: 23604123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 is neither sufficient nor required for epithelial-mesenchymal transition in LS174T colorectal cancer cells.
    Jägle S; Dertmann A; Schrempp M; Hecht A
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1226-1232. PubMed ID: 27923654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition.
    Feng J; Hu S; Liu K; Sun G; Zhang Y
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
    Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
    Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missing Links in Epithelial-Mesenchymal Transition: Long Non-Coding RNAs Enter the Arena.
    Wang L; Yang F; Jia LT; Yang AG
    Cell Physiol Biochem; 2017; 44(4):1665-1680. PubMed ID: 29216625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling the modules of EMT and stemness: A tunable 'stemness window' model.
    Jolly MK; Jia D; Boareto M; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2015 Sep; 6(28):25161-74. PubMed ID: 26317796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
    Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
    Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
    Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
    J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
    Lee JY; Kong G
    Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy.
    Chou YS; Yang MH
    J Chin Med Assoc; 2015 Aug; 78(8):438-45. PubMed ID: 26078096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.